DRY HEAT TREATMENT STABILIZER FOR HUMAN BLOOD COAGULATION FACTOR VIII AND USE THEREOF

摘要

Provided is a dry heat treatment stabilizer for human blood coagulation factor VIII, which comprises the following proportions of components: 0.005 M-0.015 M of sodium citrate, 0.001 M-0.002 M of calcium chloride, 0. 15 M-0.25 M of arginine hydrochloride, and 6-10 g/L of human serum albumin. Also provided are a human blood coagulation factor VIII preparation and a preparation method therefor. The dry heat treatment stabilizer for human blood coagulation factor VIII can maintain the activity of human blood coagulation factor VIII.